EV Biologics Approves Plan to Scale Up Exosome Drug Manufacture

The company has been in talks with several biotech and pharma manufacturing companies to develop cGMP bioprocessing and enable large-scale extracellular vesicle biomanufacturing.

The post EV Biologics Approves Plan to Scale Up Exosome Drug Manufacture appeared first on GEN – Genetic Engineering and Biotechnology News.

Published on Fri, 26 Feb 2021 21:00:42 +0000 and delivered to you by power automate collection contains value